Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway (original) (raw)
Vallance, Patrick and Leiper, James 
ORCID: https://orcid.org/0000-0003-4656-519X(2004) Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway.Arteriosclerosis, Thrombosis, and Vascular Biology, 24(6), pp. 1023-30. (doi: 10.1161/01.ATV.0000128897.54893.26) (PMID:15105281)
Full text not currently available from Enlighten.
Abstract
An increasing number of reports indicate that endogenously produced inhibitors of nitric oxide synthase, particularly asymmetric dimethylarginine (ADMA), regulate nitric oxide generation in disease states. This article describes the biology of ADMA and the implications for cardiovascular physiology and pathophysiology.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Leiper, Professor James |
| Authors: | Vallance, P., and Leiper, J. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health |
| Journal Name: | Arteriosclerosis, Thrombosis, and Vascular Biology |
| Publisher: | American Heart Association |
| ISSN: | 1079-5642 |
| ISSN (Online): | 1524-4636 |
| Published Online: | 22 April 2004 |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
| ID Code: | 153271 |
|---|---|
| Depositing User: | Ms Mary Anne Meyering |
| Datestamp: | 08 Dec 2017 15:03 |
| Last Modified: | 30 Mar 2025 02:37 |
| Date of acceptance: | 8 April 2004 |
| Date of first online publication: | 22 April 2004 |